Araz Marachelian
Pediatric Hematology-Oncology · Los Angeles, CANPI 1871693945
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $15,933 of the $20,729 with a category attached, or 76.9%. 7 manufacturers reported payments, led by Y-mabs Therapeutics, Inc. at 45.5% of the total. Reporting peaked in 2022 at $12,053 and has fallen 50.4% since, to $5,974 in 2025.
Across 31 payments — averaging $668.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Y-mabs Therapeutics, Inc.$9K
- Recordati_rare_diseases_inc.$6K
- USWM, LLC$3K
- E.r. Squibb & Sons, L.L.C.$2K
- United Therapeutics Corporation$1K
- AstraZeneca$150
- plus $39 from 1 others
Across 72 payments — averaging $29,494 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- United Therapeutics Corporation$1.3M
- Pfizer$278K
- Progenics Pharmaceuticals, Inc.$260K
- Jazz Pharmaceuticals Inc.$142K
- Eli Lilly$67K
- Y-mabs Therapeutics, Inc.$43K
What the payments were for
- Consulting fees$15,93377%
- Speaking & faculty fees$3,45017%
- Food & beverage$1,3476%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Y-mabs Therapeutics, Inc. | 6 | $9,424 |
| Recordati_rare_diseases_inc. | 2 | $5,670 |
| USWM, LLC | 4 | $2,646 |
| E.r. Squibb & Sons, L.L.C. | 1 | $1,788 |
| United Therapeutics Corporation | 16 | $1,013 |
| AstraZeneca | 1 | $150 |
| Jazz Pharmaceuticals Inc. | 1 | $39 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$20,729 in reported general payments places this provider in the 80th percentile of 307 pediatric hematology-oncology providers in California.
See all pediatric hematology-oncology providers in California →
Other pediatric hematology-oncology in Los Angeles
- Noah FedermanLos Angeles$399K
- Jan van TornoutLos Angeles$137K
- Thomas CoatesLos Angeles$99K
- Andrew DietzLos Angeles$88K
- Geetha PuthenveetilLos Angeles$62K
- Hisham Abdel AzimLos Angeles$52K
- Michael PulsipherLos Angeles$45K
- Leo MascarenhasLos Angeles$35K
- Edward GompertsLos Angeles$28K
- Paibel Aguayo-HiraldoLos Angeles$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.